Open access

Site-Directed Mutagenesis Using Oligonucleotide-Based Recombineering

Written By

Roman G. Gerlach, Kathrin Blank and Thorsten Wille

Submitted: 06 May 2011 Published: 05 February 2013

DOI: 10.5772/46241

From the Edited Volume

Genetic Manipulation of DNA and Protein - Examples from Current Research

Edited by David Figurski

Chapter metrics overview

2,652 Chapter Downloads

View Full Metrics

1. Introduction

Methods enabling mutational analysis of distinct chromosomal locations, like site-directed mutagenesis, insertion of foreign sequences or in-frame deletions, have become of fast growing interest since complete bacterial genome sequences became available. Various approaches have been described to modify any nucleotide(s) in almost any manner. Some genetic engineering technologies do not rely on the in vitro reactions carried out by restriction enzymes and DNA ligases (Sawitzke et al., 2001). Complicated genetic constructs that seem to be impossible to generate in vitro can be created within one week using in vivo technologies (Sawitzke et al., 2001).

Over several decades, researchers developed and refined various strategies for genetic engineering that make use of the homologous recombination system. Its natural main functions are restoring collapsed replication forks, repairing damage-induced double-strand breaks and maintaining the integrity of the chromosome (Poteete, 2001).

We want to focus on a technique for recombination-mediated genetic engineering ("recombineering", Copeland et al., 2001). Recombineering requires only minimal in vitro effort. It has been applied to Escherichia coli, Salmonella, and a range of other Gram-negative bacteria, as well as to bacteriophages, cosmids and bacterial artificial chromosomes (BACs). It was demonstrated that single-stranded DNA (ssDNA) oligonucleotides can be used as substrates for recombineering in E. coli (Ellis et al., 2001, Heermann et al., 2008) and BACs (Swaminathan et al., 2001). However, most commonly linear, double-stranded DNA (dsDNA) has been used as the targeting construct (Maresca et al., 2010), e.g., for chromosomal gene replacement (Murphy, 1998), whole gene disruption (Datsenko et al., 2000) or the development of novel cloning strategies, including subcloning of BAC DNA (Lee et al., 2001).

In the early 1990s, the DNA double-strand break and repair recombination pathway proved to be very efficient for recombining incoming linear DNA with homologous DNA in the yeast Saccharomyces cerevisiae (Baudin et al., 1993). For generating null alleles of a distinct gene, a PCR-amplified HIS3 selectable marker flanked by homologous sequences to the ORF (ranging from 35 to 51 nucleotides in length) was used to transform a recipient strain lacking the complete HIS3 gene or a strain containing the His3Δ200 allele. Due to the auxotrophic selection marker, transformants bearing the expected mutation were among the His+ clones, with up to 80% efficiency (Baudin et al., 1993).

In contrast to S. cerevisiae, E. coli fails to be readily transformable with linear DNA fragments because of rapid DNA degradation by the intracellular RecBCD exonuclease activity (Lorenz et al., 1994). Mutants defective in the RecBCD nuclease exhibit no degradation of linear DNA in E. coli, but unfortunately these strains are also deficient for any recombination events. This recombination defect can be partially rescued in strains with recA+ background (Jasin & Schimmel, 1984). Other mutants defective in recBC (or either recB or recC) carrying an additional suppressor mutation, sbc (suppressor of recB and recC), possess activation of the RecET recombination pathway (sbcA) or enhanced recombination by the RecF pathway (sbcB). recE and recT are found on the defective lambdoid E. coli prophage Rac and encode an exonuclease and a ssDNA-binding/strand-exchange protein, respectively (Fouts et al., 1983, Poteete, 2001). Expression of recET is induced by few cis-acting point mutations, e. g. sbcA6 (Clark et al., 1994).

One highly applicable RecET-mediated recombination reaction, termed ‘ET-cloning’, combines a homologous recombination reaction between linear DNA fragments and circular target molecules, like BAC episomes (Zhang et al., 1998). After co-transformation of linear and circular DNA molecules, only recBC sbcA recipient strains resulted in the intended recombination products (insertion or deletion). Recombination was more efficient with increasing length of the homology arms, and some constructs showed higher efficiency with increasing distance between the two homology sites (Zhang et al., 1998). For ET-cloning in recBC+ strains, which are commonly used as hosts for P1, BAC or PAC episomes, a plasmid encoding the recombination functions was constructed. In pBAD-ETγ, recE is under the control of an inducible promoter; and recT is expressed from a strong constitutive promoter. To inhibit RecBC-mediated degradation of linear DNA, the λ gam, encoding the Redγ protein, was incorporated on the plasmid (Zhang et al., 1998). Later, E. coli hosts with chromosomally-encoded, inducible recombinases have been developed to allow easy manipulation of BAC DNA (Lee et al., 2001).

1.1. The bacteriophage λ Red recombination system

Besides the mutagenesis pathway described above, Red recombination is one of the most commonly exploited techniques to foster recombination between the bacterial chromosome and linear dsDNA introduced into the cell (Murphy, 1998). The Red recombination system of the bacteriophage λ leads to a precise and rapid approach with greatly enhanced rates of recombination, compared to those found in recBC, sbcB or recD mutants. Its ability to catalyze the incorporation of PCR-generated DNA species led to an immense spread of the system. Numerous groups have developed various methodologies tailored to a variety of scientific questions. Besides the high recombination rate, the biggest advantage of the λ Red system, compared to previously used recombination systems, is that it accepts very short regions of homologous DNA (stretches of less than 100 nucleotides) for recombination. Because fragments of such size can be readily synthesized, there is a high degree of freedom in designing targeting constructs for recombination.

Which components make up the λ Red system? The genes of the Red system, exo, bet, and gam, cluster together in the PL operon, which is expressed in the early transcriptional program of bacteriophage λ (Poteete, 2001). The three resulting λ Red gene products, Redα, Redβ and Redγ, are necessary to carry out homologous recombination of dsDNA. Redα, whose monomer has a Mr of 24 kDa, is responsible for a dsDNA-dependent exonuclease activity. It degrades one strand at the ends of a linear dsDNA molecule in the 5’ to 3’ direction. This generates 3’ ssDNA overhangs, which are substrates for recombination (Little, 1967). The ring-shaped trimer of Redα passes dsDNA through its center at one end, but only ssDNA emerges from the other end (Kovall et al., 1997). The Redβ protein, whose monomer has a Mr of 28 kDa, acts as a ssDNA-binding protein that anneals complementary single strands and mediates strand exchange, thus finishing the recombination process (Li et al., 1998). When bound to ssDNA, Redβ forms large rings and makes a complex with Redα to promote recombination (Passy et al., 1999). Therefore, the Redα/Redβ pair has a function analogous to that of the RecE/RecT pair. Muyrers et al. (2000b) could highlight that there are specific interactions between the partners of each recombination system. The exonuclease RecE does not form complexes with the strand exchange protein Redβ or vice versa; Redα does not interact with RecT. Finally, the Redγ polypeptide, whose Mr is 16 kDa, protects linear dsDNA from degradation by binding the RecBCD protein and inhibiting its nuclease activities (Murphy, 1991).

1.2. Use of λ Red recombination for manipulation of bacterial genomes

The basic strategy of the λ Red system is the replacement of a chromosomal sequence with a (e.g., PCR-amplified) selectable antibiotic resistance gene flanked by homology extensions of distinct lengths. For genetic engineering in the E. coli chromosome, two efficient λ Red-mediated methods were developed by two independent groups. The first method utilized E. coli strains containing the PL operon of a defective λ prophage (e.g., deletion of cro to bioA genes, which includes the lytic genes) under control of the temperature-sensitive λ cI-repressor (allele cI857, Yu et al., 2000). To express high levels of the PL operon, cultures were shifted from repressing conditions at 32°C to inducing conditions at 42°C for 7.5 to 17.5 minutes. This was optimal for achieving maximal recombination levels. By shifting the cells back to 32°C, further expression of the PL operon was repressed; and cell death was prevented. Furthermore, the absence of the Cro-repressor enabled PL operon expression to be fully derepressed when the cI-repressor was inactivated under heat induction (Yu et al., 2000). Electroporation of this transiently induced λ lysogen with a short linear, PCR-generated dsDNA segment resulted in efficient recombination events (Poteete, 2001).

The second very efficient λ Red-mediated recombination approach, involved a low-copy plasmid with λ gam, bet, and exo under control of an arabinose-inducible promoter (pKD46, Datsenko et al., 2000). The plasmid pKD46 yielded greatly enhanced recombination events and was preferable to the similar pKD20. However, both harbor the Red system under a well-regulated promoter to avoid undesired reactions under non-inducing conditions and a temperature-sensitive replicon to allow for easy curing of the respective plasmid after recombination (Datsenko et al., 2000). For generating gene disruptions within the E. coli chromosome, the R6Kγ ori-based suicide plasmids pKD3 and pKD4 were used as templates to amplify the chloramphenicol (cat) or kanamycin (aph) resistance gene cassettes, respectively, in a PCR. Using primer pairs with site-specific homology extensions to amplify the resistance cassette, the resulting PCR product was used to transform a freshly competent E. coli expressing λ Red from pKD46. After successful recombination, the resistance gene cassette can be excised by Flp recombinase supplied in trans (1.2.3, Fig. 1).

One example of a possible refinement of the λ Red procedure promotes high-frequency recombination using ssDNA substrates. It has been discovered that only λ Redβ is absolutely required for ssDNA recombination (Ellis et al., 2001). Neither exo nor gam causes a dramatic effect on the recombination efficiency. Only a minor 5-fold reduction was observed in the gam deletion strain, most likely attributed to the single-stranded nuclease activity of the RecBCD protein complex, which is not inhibited in a gam-deficient strain (Ellis et al., 2001, Wang et al., 2000). λ Redβ bound to ssDNA is able to protect the DNA segment from nuclease attack, which might explain the recombination events that occured despite the gam deletion (Karakousis et al., 1998).

These methods offer a technology for studying bacterial gene functions or even for introducing mutations or markers in the chromosomes of eukaryotic cells, e.g., to provide special ‘‘tags’’ in the DNA of living cells (Ellis et al., 2001).

1.2.1. Gene deletion

λ Red recombination has been successfully used for convenient generation of gene deletions in E. coli (Datsenko et al., 2000), Salmonella enterica (Hansen-Wester et al., 2002), Pseudomonas aeruginosa (Liang et al., 2010, Quénée et al., 2005), Streptomyces coelicolor (Gust et al., 2004), Shigella spp. (Ranallo et al., 2006), Yersinia pseudotuberculosis (Derbise et al., 2003) and Y. pestis (Sun et al., 2008).

The first step in generating gene deletions is creating a linear targeting construct which consists usually of a resistance gene (“res” in Fig. 1) flanked by terminal extensions homologous to the sequences surrounding the deletion site. In Fig. 1, the homologous regions used for deletion of orf2 are depicted in blue and red. In the simplest approach, substrates for Red recombination can be generated by adding short homology extensions to PCR primers and using them to amplify a resistance cassette (Datsenko et al., 2000, Yu et al., 2000, Zhang et al., 2000). The length of the homology arms required for efficient recombination depends on the organism. For example, 36-50 bp (base pairs) were shown to work for E. coli or Salmonella enterica (Datsenko et al., 2000, Hansen-Wester et al., 2002) and 50-100 bp for Pseudomonas aeruginosa (Liang et al., 2010). Much longer homology arms were required for efficient Red recombination in Y. pseudotuberculosis and Y. pestis (~500 bp, Derbise et al., 2003, Sun et al., 2008) and Vibrio cholerae (100-1000 bp, Yamamoto et al., 2009). For the latter examples, multiple PCRs have to be done to generate functional targeting constructs.

In the next step, the PCR product is used to transform bacteria expressing λ Red proteins. Homologous recombination results in insertion of the cassette at the precise position determined by the homology extensions (Fig. 1). Transformants can be selected using their acquired antibiotic resistance. Target regions for site-specific recombinases (Fig. 1, yellow triangles) provide the option for subsequent removal of the resistance cassette (see also 1.2.3).

1.2.2. DNA insertion

In addition to removing DNA from bacterial genomes (1.2.1), λ Red recombination can also be applied to precisely insert any DNA within a genome. This approach has been widely used for analyzing bacterial gene expression via the generation of reporter gene fusions (Gerlach et al., 2007a, Lee et al., 2009, Yamamoto et al., 2009) or epitope tagging (Cho et al., 2006, Lee et al., 2009, Uzzau et al., 2001). In a similar approach, promoter sequences can be inserted or exchanged within the genome (Alper et al., 2005, Wang et al., 2009).

Figure 1.

Deletion of orf2 using λ Red recombination and subsequent removal of resistance marker (res) via Flp or Cre recombinase. Red and blue regions denote regions of homology. The yellow region denotes the target for the site-specific recombinase.

In these cases, the targeting construct includes besides a selectable marker the DNA to be inserted. Using primers with homology extensions, these targeting constructs can be amplified by PCR from sets of template vectors available for different reporter genes (e.g., ß-galactosidase, luciferase, green fluorescent protein (gfp) and epitope tags (e.g., Flag®, haemagglutinin (HA), 8xmyc, 6xHis). An interesting alternative that obviates the need for multiple template vectors was developed by Gust et al. (2004). The resistance cassette and the reporter gene were amplified in separate PCRs, using in each reaction only one primer with the homology extension for Red recombination. The other primers included regions of homology to each other to allow them to anneal. The joint molecule was then used in a second round of PCR to generate a fusion cassette.

Depending on the scientific question to be answered, different integration strategies for reporter genes are available. For transcriptional fusions, a promoterless reporter gene is inserted downstream of a promoter of interest. The reporter gene may have optimized translational signals, including an optimized ribosome binding site (RBS) at the optimal distance from the start codon. If such a construct is inserted within an operon, hybrid operons are generated (Gerlach et al., 2007a). We have introduced so-called “start codon fusions,” in which the reporter gene is inserted behind the native RBS and start codon of the gene under study, so that expression is assessed in the native genomic context (Gerlach et al., 2007a, Wille et al., 2012). This gene fusion strategy is closely related to translational fusions. The classical Red recombination protocol enables the easy generation of C-terminal fusion proteins, in which the reporter gene or epitope tag is inserted in-frame at any position in an open-reading-frame (ORF). For the generation of N-terminal fusions, a “scarless“ recombination protocol (see 2.) has to be applied.

1.2.3. Site-specific recombination for removal of antibiotic resistance genes

Several methods, involving various site-specific recombination systems, have been developed for the removal of unwanted marker sequences from the chromosome. The most frequently used site-specific recombinases for subsequent excision of antibiotic resistance genes are Flp and Cre. Flp and Cre recombinases recognize 34-bp long sequences with palindromic elements (FRT and loxP, respectively). Both sites, FRT and loxP, consist of two 13-bp inverted repeats flanking an 8-bp non-palindromic core sequence. The asymmetry of the core sequence determines the polarity of the recombination site and has extensive consequences for the outcome of the recombination. Recombination between directly orientated recombination sites leads to excision of the intervening sequence (Fig. 1, yellow triangles), while recombination between inverted recombination sites results in an inversion of the intervening sequence. Recombination continuously takes place as long as the recombinase is present (Schweizer, 2003, Zhang et al., 2002). However, removal of resistance genes by either one of the site-specific recombinases leaves a loxP or FRT “scar” sequence within the genome (Datsenko et al., 2000, Lambert et al., 2007).

Although there is limited homology between the scar sequences themselves, they might serve as hotspots for recombination in successive recombination steps, representing a risk for unwanted deletions or chromosomal rearrangements (Datsenko et al., 2000). In addition, these scars might have influence on gene functions when operon structures or intragenic regions were modified (Blank et al., 2011). Mutations within the inverted repeats of loxP, resulting in the lox66 and lox71 alleles, can minimize genetic instability. Recombination using either generates lox72, which has a strongly reduced binding affinity for Cre (Lambert et al., 2007).


2. Site-directed mutagenesis using oligonucleotides

Precise insertion of chromosomal mutations has been established as the “gold standard” for analysis of bacterial gene function. Generation of point mutations, seamless deletions and in-frame gene fusions without leaving selectable markers or a recombination target site (e.g., loxP or FRT) requires reliable counterselectable markers. The published protocols are usually based on two successive rounds of recombination: (I) integration of a positively selectable marker (e.g., an antibiotic resistance gene) in the first step and (II) selection for marker loss (counterselection) in the final recombination step (Reyrat et al., 1998). Some of the counterselection methods have been shown to function together with the recombination of short synthetic DNA fragments. This circumvents the tedious and time-consuming requirement for PCR-based mutagenesis and cloning to generate mutant alleles for the second recombination step.

2.1. Counterselection with SacB

The Bacillus subtilis sacB gene is widely used as a genetic tool for counterselection puposes. SacB confers sucrose sensitivity to a wide range of Gram-negative bacteria (Blomfield et al., 1991, Kaniga et al., 1991). The levansucrase SacB catalyzes transfructorylation from sucrose to various acceptors, hydrolysis of sucrose and synthesis of levans (Gay et al., 1985). The molecular basis of its toxic effect on many Gram-negative bacteria is still not completely understood. It is thought that accumulation of levans in the periplasm or transfer of fructose residues to inappropriate acceptors, subsequently generating toxic compounds, might play an important role (Pelicic et al., 1996).

Linear targeting constructs harboring sacB combined with a kanamycin resistance gene (neo, Zhang et al., 1998), an ampicillin resistance gene (bla, Liang et al., 2010) or a chloramphenicol resistance gene (cat, Sun et al., 2008) were used for the first recombination rounds. An interesting marker combining the ability for positive selection and counterselection in one fusion gene is sacB-neo. The resulting protein SBn confers kanamycin resistance, as well as sucrose sensitivity, to Gram-negative bacteria.

The latter two methods were used to generate gene deletions within the chromosomes of P. aeruginosa and Y. pestis, respectively. In these organisms, the λ Red system was used to recombine the targeting constructs with homology extensions of 50-100 bp (Liang et al., 2010) or ~500 bp (Sun et al., 2008) flanking the cassettes.

In the homologous recombination step, clones were selected for the respective antibiotic resistance. Recombinants were selected on medium plates containing 5-7% sucrose to select for loss of the cassette. Exact timing of counterselection is a critical issue when working with SacB or SBn, since sacB-inactivating mutations were shown to accumulate. For example, only 10-15% (not 100%) of sacB-clones lost their kanamycin resistance after counterselection of SBn on sucrose plates (Muyrers et al., 2000a). Nevertheless, Muyrers and coworkers successfully used this selection scheme to introduce a point mutation within a BAC. In these experiments, the altered base was included in one of the homology arms of both targeting constructs. Interestingly, the investigators observed that the homologous arms for the second targeting construct should be at least 500 bp in length. This excludes the use of a completely synthetic oligonucleotide at that step (Muyrers et al., 2000a).

2.2. Dual selection of recombinants with GalK or ThyA

Besides the fusion protein SBn, E. coli galactokinase (GalK) and thymidylate synthase A (ThyA) can each be used in the dual role of both a positive selective marker (selection for the gene) and a negative selective marker (selection for the absence of the gene). Depending on the substrates used for growing recombinants, gain or loss of the markers can be selected very efficiently. Both systems were established for the manipulation of BACs in appropriate E. coli host strains that are deficient for galK or thyA and have the λ Red recombination system present within their genomes (Wong et al., 2005, Warming et al., 2005). These methods cannot be used for site-directed mutagenesis of genomes of bacteria with functional galK or thyA.

The galETKM operon enables E. coli to metabolize D-galactose (Semsey et al., 2007). In the initial step, GalK catalyzes the phosphorylation of D-galactose to galactose-1-phosphate. Recombinants were selected after the first recombination step with D-galactose as the sole carbon source. A functional GalK is absolutely required for growth under these conditions. Besides D-galactose, GalK can efficiently phosphorylate a galactose analog, 2-deoxy-galactose (DOG). Because the product 2-deoxy-galactose-1-phosphate cannot be further metabolized, it is enriched to toxic concentrations (Alper et al., 1975). In the second recombination step, an oligonucleotide harboring the desired mutation was used as substrate for Red recombination. Loss of GalK was selected on plates containing glycerol as sole carbon source and DOG (Warming et al., 2005).

A thyA mutation results in thymine auxotrophy of E. coli, since the enzyme is required for dTTP and, therefore, DNA de novo synthesis. Integration of the thyA-containing targeting construct in the first recombination step was selected on minimal medium in the absence of thymine. For its function, ThyA requires tetrahydrofolate (THF) as a cofactor. During the process THF is oxidized to dihydrofolate (DHF). The pool of THF is replenished from DHF by dihydrofolate reductase (DHFR). The action of DHFR can be inhibited by the antibiotic trimethoprim. Using a growth medium supplemented with trimethoprim and thymine, loss of thyA was selected in the second round of recombination. At this step, a PCR product containing a mutated allele was applied as targeting construct (Wong et al., 2005).

2.3. Counterselection using streptomycin resistance

Several mutants of the ribosomal protein S12 (RpsL) were shown to confer streptomycin resistance (SmR, Springer et al., 2001). Strains harboring such an rpsL allele (e.g., rpsL150) can be used as hosts in another counterselection method. The main principle is based on the fact that streptomycin resistance-conferring mutations are recessive in merodiploid strains (Lederberg, 1951). In the first step, the wild type (wt) allele of rpsL was inserted within the gene of interest using λ Red or RecE/T recombination (1.1). A cassette containing an rpsL-neo fusion gene was used. Clones exhibited KmR and SmS (Heermann et al., 2008). The desired point mutation for the gene of interest had already been introduced into one of the two 50-bp homology arms of the rpsL-neo cassette. The rpsL-neo cassette was then deleted in a second round of recombination. For this step, a single-stranded oligonucleotide containing no rpsL allele but containing arms of homology to the gene of interest were used. To maintain the mutation, one of the homology arms again harbored the desired mutation. Recombinants that deleted the wt rpsL could be selected by their resistance to streptomycin. After successful recombination, the wt copy of rpsL was removed, and the gene of interest was re-established, now containing the desired mutation (Heermann et al., 2008).

2.4. Selection with the fusaric acid sensitivity system

A counterselection technique developed by Bochner et al. (1980) enables direct selection of tetracycline sensitive (TcS) clones from a predominantly tetracycline resistant (TcR) bacterial population. The method is based on the hypersensitivity of lipophilic TcR cells to chelating agents, like fusaric acid or quinaldic acids. The precise mechanism of tetracycline exclusion is so far unknown and the subject of much speculation. The hypersensitivity seems to be caused by alterations of the host cell membrane, which are evoked from the expression of the tetracycline resistance gene. These alterations interfere, on one hand, with tetracycline permeation to confer tetracycline resistance, but, on the other hand, also to increase susceptibility to other toxic compounds (Bochner et al., 1980). This effect was exploited by using a medium that was effective for the selection of TcS revertants. The counterselection was successful in Salmonella; but it was much less effective with most, especially fast-growing, E. coli strains (Bochner et al., 1980). Decreasing the nutrient concentration of the selection plates significantly minimized the background of TcR colonies of fast-growing bacteria (Maloy et al., 1981).

The counterselection of TcR clones on Bochner-Maloy plates was sometimes used as the final step in recombineering protocols. Point mutations were inserted in BACs using a combination of λ gam (1.1) with RecE/T (1.) to integrate the gene for tetracycline resistance.

Figure 2.

Use of a tet cassette in conjunction with Bochner-Maloy TcS-selective medium for counterselection. Blue and red regions denote regions of homology. “mut” indicates a mutation. The mutation is first in the targetting construct, then recombination transfers it to “orfX” (”orfX”mut). “PX” designates the promoter for orfX; “Ω” indicates a transcriptional terminator.

A PCR product carrying the desired mutation was used in the second recombination step to exchange tet. Recombinants (TcS) were selected on Bochner-Maloy plates (Nefedov et al., 2000). Similar two-step recombination approaches were also used to manipulate the genome of Salmonella enterica serovar Typhimurium (“S. Typhimurium”) (Gerlach et al., 2009, Karlinsey, 2007). For this technique, a tetAR cassette, which encodes TcR, was inserted in the first step within a target gene (“orfX”) with the help of homology extensions (blue and red, Fig. 2) resulting in tetracycline resistant clones. In the second recombination step, either PCR-derived mutant alleles (Karlinsey, 2007) or synthetic oligonucleotides (Gerlach et al., 2009) were used as targeting constructs to remove the tetAR cassette. For the latter rationale, no further cloning steps to generate the mutant allele (Fig. 2 “mut”) were required. The applicability of this approach was proven with a Salmonella virulence-associated gene as an example. siiF encodes the putative ATPase of a type I secretion system (T1SS) located within the Salmonella Pathogenicity Island 4 (SPI-4, Gerlach et al., 2007b). Previous work on a homologue demonstrated, that a single amino acid exchange within the Walker Box A of the ABC (ATP-binding cassette) motif disrupted the function of the transport ATPase (Koronakis, 1995). For our mutagenesis of siiF, we designed oligonucleotides to introduce a silent mutation resulting in a novel NlaIV site (2.6.1), as well as a change of Gly at position 500 to Glu (G500E) or a change of Lys at position 506 to Leu (K506L). Both amino acid positions are within the ABC motif. As a control, we introduced a silent mutation to generate a new SacI restriction site (2.6.1) within siiF. After growth selection on Bochner-Maloy medium plates that favor the growth of TcS bacteria, clones were screened for the newly inserted restriction sites by the relevant restriction enzymes. Positive recombinants were subjected to functional analyses. The experiments showed the expected results: (I) no influence of the silent mutations and (II) loss of substrate secretion from the amino acid exchanges within Walker Box A (Gerlach et al., 2009).

The selection efficiency of Bochner-Maloy plates was reported not to exceed 50% (Podolsky et al., 1996). Therefore, the selection procedure was not very stringent. Exact timing of all incubation steps was necessary; but still high background might be observed, making purification of positive clones difficult. Highly increased selection efficiencies were obtained with plates containing 5-7 mM NiCl2, which led to 80-100% positive TcS revertants (Podolsky et al., 1996).

2.5. Double-strand breaks introduced by I-SceI can be used to select recombinants

The endonuclease I-SceI of the yeast Saccharomyces cerevisiae is a novel tool for counter-selection. I-SceI is an endonuclease with a long recognition sequence of 18 bp, thus ensuring the statistical absence of natural I-SceI recognition sites within bacterial genomes (Monteilhet et al., 1990). Counterselection with I-SceI is based on the induction of lethal double-strand breaks (DSB) within the genome or BAC, thus inhibiting DNA propagation. The Red system promotes enough recombination that recombinants can be obtained by screening survivors.

Several methods for site-directed mutagenesis of BACs and/or bacterial genomes utilizing I-SceI expression have been published. Usually the methodologies are based on the insertion of an I-SceI recognition sequence together with a positively selectable marker near the sequence to be modified. Furthermore, a system allowing for transient expression of the I-SceI restriction enzyme in a coordinated fashion after expression of the λ Red recombination system is required. For the manipulation of BACs, a special E. coli host strain was developed to facilitate the independent expression of λ Red and I-SceI. E. coli GS1783 harbors within its genome λ Red under control of a temperature-sensitive repressor and I-SceI under control of an arabinose-inducible promoter (Tischer et al., 2010). However, for modification of bacterial genomes the components for recombination and I-SceI have to be provided on one or two plasmid(s). The single plasmid solutions allow for independent inducible expression of both functions using arabinose and tetracycline (pWRG99 and pGETrec3.1; Blank et al., 2011, Jamsai et al., 2003) or arabinose and rhamnose (pREDI, Yu et al., 2008).

For mutagenesis of the genomes of Salmonella enterica servoar Enteritidis (S. Enteritidis, Cox et al., 2007) and E. coli (Kang et al., 2004), setups with the Red components and I-SceI encoded on two separate plasmids were used. Targeting constructs consisting of an I-SceI recognition site, a KmR cassette and long flanking homology regions (>200 bp) were constructed in a two-step PCR approach. After chromosomal integration of the linear DNA via λ Red-mediated recombination, clones were selected with kanamycin (Cox et al., 2007). A two-step PCR approach was used to combine long extensions homologous to lamB with sequences encoding antigen epitopes in the second targeting construct. For production of antibodies against foreign proteins, epitopes were inserted into the outer membrane protein LamB to facilitate surface presentation. This linear PCR product was used in a co-transformation with pBC-I-SceI at a molar ratio of 40:1 (PCR product:plasmid) into λ Red-expressing S. Enteritidis. I-SceI was constitutively expressed from plasmid pBC-I-SceI (Kang et al., 2004). Screening for the desired recombinants was based on the inability to grow on kanamycin-containing plates (Cox et al., 2007). Because there is no convenient possibility for plasmid curing, the pBluescript (Stratagene)-based pBC-I-SceI remains in the host strains (Cox et al., 2007, Kang et al., 2004).

GET recombination is a method developed for the manipulation of BACs. It employs λ Gam and RecE/T for recombination (1.1) and I-SceI for counterselection (Jamsai et al., 2003). In a study by Jamsai et al. (2003), the I-SceI endonuclease gene downstream of a repressed promoter, together with a constitutive gene for KmR and an I-SceI recognition site, was inserted within the gene of interest in the first recombination step. As targeting construct for the second recombination step, a 1708-bp PCR product carrying the desired mutation was inserted in exchange for the I-SceI-kanamycin resistance cassette. I-SceI expression was induced for 30 minutes with addition of heat-treated chlorotetracycline. Expression was induced from both the inserted I-SceI-kanamycin resistance cassette and plasmid pGETrec3.1 (Jamsai et al., 2003). The kanamycin resistance cassette, with its I-SceI recognition site, was successfully removed from 23.6% of the colonies surviving expression of I-SceI (Jamsai et al., 2003).

Because no specific mechanisms were implemented in pGETrec3.1 and pBC-I-SceI to promote convenient plasmid curing, it might be difficult to get plasmid-free host strains after site-directed mutagenesis. We solved that problem by integrating a tetracycline-inducible I-SceI expression cassette from pST98-AS (Pósfai et al., 1999) in the temperature-sensitive λ Red expression plasmid pKD46 (Datsenko et al., 2000) to generate pWRG99 (Blank et al., 2011). In a first recombination step, a CmR cassette (cat) together with an I-SceI recognition site (dark green, Fig. 3A) was integrated within phoQ in the genome of S. Typhimurium. For that, extensions of 40 nt length homologous to the regions surrounding the intended mutation site within phoQ were added to the primers (Fig. 3A, blue and red). PhoQ is the histidine sensor kinase of the Salmonella virulence-associated two-component signaling system PhoPQ. Successful recombinants were selected using chloramphenicol, and correct integration of the resistance cassette was checked by colony PCR and sequencing. For the second round of recombination, 80mer dsDNAs, derived from oligonucleotides, were introduced into pWRG99-harboring cells expressing λ Red recombination genes. These 80mer dsDNAs were designed (I) to delete the phoQ gene (not shown) or (II) to introduce a threonine to isoleucine exchange at position 48 (T48I) of PhoQ, together with a new SacII restriction site (Fig. 3A). Expression of I-SceI was induced with addition of anhydrotetracycline (AHT) leading to lethal DSBs in the clones still harboring the I-SceI recognition site. Surviving clones were screened by PCR, restriction analysis using SacII as well as phenotypically. The single amino acid exchange T48I within the periplasmic domain of PhoQ results in constitutive activation of the response regulator PhoP (Miller, 1990). Besides virulence attenuation, constitutive PhoP activation leads to overexpression of the nonspecific acid phosphatase PhoN. Successful recombinants could therefore be screened phenotypically by forming blue colonies on 5-bromo-4-chloro-3-indolyl-phosphate toluidine salt (BCIP) plates due to increased PhoN activity. Correct recombination events could be further confirmed by a macrophage infection model, which showed the predicted virulence-attenuated phenotype (Blank et al., 2011).

Figure 3.

Methods for single nucleotide exchange using I-SceI counterselection. Details for A and B are in the text. The symbols and colors are the same as those described in Fig. 2. However in A orfX is phoQ. The antibiotic resistance is CmR; the resistance gene is cat. The mutation (inverted triangle) is a point mutation that changes threonine at position 48 in PhoQ to isoleucine (T48I). The green rectangle is the recognition site for the I-SceI endonuclease; “DSB” is the “double-strand break” induced by I-SceI. In B, the symbols are the same as those in A and Fig. 2. Unique to B are “res” (antibiotic resistance) and the modular extensions for the primers (orange, blue, red, and light green). All are homologous to orfX. The two internal primers (relative to the intact gene) have the blue and red extensions, which will become the duplicated region. The “left” primer has unique homology (orange); the “right” primer has unique homology (light green).

The Red recombination system can anneal single-stranded DNA derived from dsDNA substrates into replicating homologous target sequences (1.1). Usually homologous sequences for recombination are supplied with the homology extensions flanking the targeting construct. In contrast, homologous regions flanking a DSB generated by I-SceI can also act as substrates for Red recombination. This strategy has been used for scarless site-directed mutagenesis of BACs (Tischer et al., 2010, Tischer et al., 2006) and the E. coli genome (Yu et al., 2008). These approaches require the integration of a duplicated sequence stretch in the first recombination round to serve as a substrate for recombination in the second round. For seamless deletions or insertion of point mutations, the duplications can be readily incorporated within the primers used to amplify the positive selection marker. In one study, modular sequence extensions, each ~20 nt in length (Fig. 3B; orange, blue, red and light green), were added to the primers used to amplify a resistance cassette (res). The two primers were unique but shared about 40 nt of sequence. The desired mutation (Fig. 3B, inverted triangles) was included in the duplicated sequence. This resulted in a ~40-bp sequence duplication (red and blue) after integration of the targeting construct into the gene of interest (orfX) via Red recombination (Fig. 3B, Tischer et al., 2010). The duplicated sequences were separated by the I-SceI recognition site and after induction of DSB, the Red-mediated recombination between these sequences led to the reconstitution of orfX in its mutated form orfXmut (Fig. 3B). Figure 3B shows a generalization of this strategy. If longer DNA sequences need to be integrated (1.2.2), a preceding cloning step is required to insert the selectable marker together with the I-SceI recognition site and a sequence duplication into the DNA to be inserted (Tischer et al., 2010). Combining I-SceI-induced DSB with SacB-mediated sucrose sensitivity (2.1) was shown to improve selection for loss of resistance marker within the E. coli genome (Yu et al., 2008).

One major problem of the I-SceI counterselection approach is the accumulation of point mutations within or deletion of the I-SceI recognition site during the selection process. This effect demands tight regulation of I-SceI expression to minimize selection pressure before the final (markerless) recombination takes place. It was important to optimize the procedures to maximize counterselection after the 2nd round of recombination.

2.6. Screening methods for recombinants

An underestimated problem is the screening effort needed to identify correct recombinants when using seamless recombination techniques. Although PCR fragment length polymorphism can be used in case of deletions and insert-specific PCRs in case of DNA insertion, successful single nucleotide exchanges are hard to detect. Direct phenotypical screening or the parallel introduction of novel restriction sites together with the nucleotide exchange are solutions of the problem.

2.6.1. Introduction of silent mutations to generate novel restriction sites

A screening problem arises if mutations introduced via recombineering have no direct or indirect impact on the phenotype or if the phenotypic test required is very time-consuming. Introduction of a novel restriction site adjacent to the mutation was proven to be very useful for colony screening. Designing the oligonucleotides for λ Red recombination offers the prospect of introducing silent mutations in the target region. Identification of silent mutations generating novel restriction sites can be done in silico using WatCut [an online tool for restriction analysis, silent mutation scanning and SNP-RFLP analysis (] or other DNA analysis software (e.g., Clone Manager). As mentioned before, this screening method has been used successfully [e.g., for screening siiF recombinants by introducing a new NlaIV and/or SacII restriction site (2.4), as well as for the phoQT48I mutation by generating a novel SacII restriction site (2.5)].

2.6.2. Phenotypical screening

If available, phenotypical screening is the fastest way for selecting recombinants with the desired mutation. The screening is based on phenotypic differences between the mutant and the wt. In the simplest case, activity of an integrated reporter gene like gfp or lacZ’ might be detected (Gerlach et al., 2007a). Another possibility for screening is the ability (gain of function) or inability (loss of function, auxotrophy) of the mutant to grow under specific conditions. In the latter case it is necessary to define permissive conditions in which the mutant can grow and restrictive conditions in which it cannot. Moreover, mutations might lead to differences in cell morphology that can be identified by microscopic examination. Last but not least, there may be a difference in the ability to utilize a chromogenic substrate, like BCIP, p-nitrophenyl-phosphate (pNPP) or 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal). These could be used for screening of positive recombinants. All of the phenotypes can originate directly from the activity of the mutated gene product or indirectly by influencing the activity and/or expression level of other proteins. One example is the PhoQ T48I mutant, which causes overexpression of PhoN. The overexpression can be monitored using the chromogenic substrate BCIP (2.5, Blank et al., 2011).


3. Conclusion

Two successive recombination steps catalyzed by the phage λ Red or phage Rac RecE/T recombination systems in combination with a negative selection procedure provide a venue for scarless mutagenesis within bacterial genomes and BACs. The outstanding ability of these enzymes to use homologous sequences as short as 35 bp as substrates for recombination allows the use of linear DNA derived from synthetic oligonucleotides as targeting constructs. The limiting step of this rationale is the availability of a reliable counterselection method. Here we gave an overview about recombination and the counterselection techniques successfully applied to the manipulation of bacterial genomes, as well as BACs.


  1. 1. AlperHFischerCNevoigtEStephanopoulosG2005Tuning genetic control through promoter engineeringProc Natl Acad Sci U S A, 1023612678126830027-8424
  2. 2. AlperM. DAmesB. N1975Positive selection of mutants with deletions of the gal-chl region of the Salmonella chromosome as a screening procedure for mutagens that cause deletions.J Bacteriol, 12112592660021-9193Print)
  3. 3. BaudinAOzier-kalogeropoulosODenouelALacrouteFCullinC1993ASimpleand efficient method for direct gene deletion in Saccharomyces cerevisiae. Nucleic Acids Res, 2114332933300305-1048
  4. 4. BlankKHenselMGerlachR. G2011Rapid and Highly Efficient Method for Scarless Mutagenesis within the Salmonella enterica ChromosomePLoS One, 61e157631932-6203
  5. 5. BlomfieldI. CVaughnVRestR. FEisensteinB. I1991Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon.Mol Microbiol, 56144714570095-0382X
  6. 6. BochnerB. RHuangH. CSchievenG. LAmesB. N1980Positive selection for loss of tetracycline resistance.J Bacteriol, 14329269330021-9193
  7. 7. ChoB. KKnightE. MPalssonB. O2006PCR-based tandem epitope tagging system for Escherichia coli genome engineering.Biotechniques40167720736-6205
  8. 8. ClarkA. JSatinLChuC. C1994Transcription of the Escherichia coli recE gene from a promoter in Tn5 and IS50.J Bacteriol, 17622702470310000-0021
  9. 9. CopelandN. GJenkinsN. ACourtD. L2001Recombineering: a powerful new tool for mouse functional genomicsNat Rev Genet, 2107697791471-0056
  10. 10. CoxM. MLaytonS. LJiangTColeKHargisB. MBerghmanL. RBottjeW. GKwonY. M2007Scarless and site-directed mutagenesis in Salmonella enteritidis chromosome.BMC Biotechnol, 7591472-6750
  11. 11. DatsenkoK. AWannerB. L2000One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR productsProc Natl Acad Sci U S A, 9712664066450027-8424
  12. 12. DerbiseALesicBDacheuxDGhigoJ. MCarnielE2003ARapidand simple method for inactivating chromosomal genes in Yersinia. FEMS Immunol Med Microbiol, 3821131160928-8244
  13. 13. EllisH. MYuDDiTizio, T. & Court, D.L. (2001High efficiency mutagenesis, repair, and engineering of chromosomal DNA using single-stranded oligonucleotidesProc Natl Acad Sci U S A, 9812674267460027-8424
  14. 14. FoutsK. EWasie-gilbertTWillisD. KClarkA. JBarbourS. D1983Genetic analysis of transposon-induced mutations of the Rac prophage in Escherichia coli K-12 which affect expression and function of recE.J Bacteriol, 15627187260021-9193
  15. 15. GayPLe Coq, D., Steinmetz, M., Berkelman, T. & Kado, C.I. (1985Positive selection procedure for entrapment of insertion sequence elements in gram-negative bacteria.J Bacteriol, 16429189210021-9193
  16. 16. GerlachR. GHölzerS. UJäckelDHenselM2007aRapid engineering of bacterial reporter gene fusions by using red recombination.Appl Environ Microbiol, 7313423442420099-2240
  17. 17. GerlachR. GJäckelDHölzerS. UHenselM2009Rapid oligonucleotide-based recombineering of the chromosome of Salmonella enterica.Appl Environ Microbiol, 756157515801098-5336
  18. 18. GerlachR. GJäckelDStecherBWagnerCLupasAHardtW. DHenselM2007bSalmonella Pathogenicity Island 4 encodes a giant non-fimbrial adhesin and the cognate type 1 secretion system.Cell Microbiol, 97183418501462-5814
  19. 19. GustBChandraGJakimowiczDYuqingTBrutonC. JChaterK. F2004LRed-mediatedgenetic manipulation of antibiotic-producing Streptomyces. Advances in applied microbiology541071280065-2164
  20. 20. Hansen-westerIHenselM2002Genome-based identification of chromosomal regions specific for Salmonella spp.Infect Immun, 705235123600019-9567
  21. 21. HeermannRZeppenfeldTJungK2008Simple generation of site-directed point mutations in the Escherichia coli chromosome using Red®/ET® Recombination.Microbial cell factories7141475-2859
  22. 22. JamsaiDOrfordMNefedovMFucharoenSWilliamsonRIoannouP. A2003Targeted modification of a human β-globin locus BAC clone using GET Recombination and an I-SceI counterselection cassette. Genomics, 82168770888-7543
  23. 23. JasinMSchimmelP1984Deletion of an essential gene in Escherichia coli by site-specific recombination with linear DNA fragments.J Bacteriol, 15927837860021-9193
  24. 24. KangYDurfeeTGlasnerJ. DQiuYFrischDWinterbergK. MBlattnerF. R2004Systematic mutagenesis of the Escherichia coli genome.J Bacteriol, 18615492149300021-9193
  25. 25. KanigaKDelorICornelisG. R1991AWide-hostrange suicide vector for improving reverse genetics in gram-negative bacteria: inactivation of the blaA Geneof Yersinia enterocolitica. Gene, 10911371410378-1119
  26. 26. KarakousisGYeNLiZChiuS. KReddyGRaddingC. M1998The beta protein of phage L binds preferentially to an intermediate in DNA renaturation. Journal of molecular biology, 27647217310022-2836
  27. 27. KarlinseyJ. E2007L-Red genetic engineering in Salmonella enterica serovar Typhimurium. In: Advanced Bacterial Genetics: Use of Transposons and Phage for Genomic Engineering, K.T. Hughes, S.R. Maloy (eds.), 199209Academic Press, 00766879York
  28. 28. 0036-8075533327718241827Kovall, R. & Matthews, B.W. (1997). Toroidal structure of λ-exonuclease. Science, Vol.277, No.5333, pp. 1824-1827, ISSN 0036-8075
  29. 29. LambertJ. MBongersR. SKleerebezemM2007Cre-lox-based system for multiple gene deletions and selectable-marker removal in Lactobacillus plantarum.Appl Environ Microbiol, 734112611350099-2240
  30. 30. LederbergJ1951Streptomycin resistance: a genetically recessive mutationJ Bacteriol, 6155495500021-9193
  31. 31. LeeD. JBingleL. EHeurlierKPallenM. JPennC. WBusbyS. JHobmanJ. L2009Gene doctoring: a method for recombineering in laboratory and pathogenic Escherichia coli strainsBMC Microbiol, 92521471-2180
  32. 32. LeeE. CYuDMartinez de Velasco, J., Tessarollo, L., Swing, D.A., Court, D.L., Jenkins, N.A. & Copeland, N.G. (2001A highly efficient Escherichia coli-based chromosome engineering system adaptedfor recombinogenic targeting and subcloning of BAC DNA. Genomics73156650888-7543
  33. 33. LiZKarakousisGChiuS. KReddyGRaddingC. M1998The beta protein of phage L promotes strand exchange. Journal of molecular biology, 27647337440022-2836
  34. 34. LiangRLiuJ2010Scarless and sequential gene modification in Pseudomonas using PCR product flanked by short homology regionsBMC Microbiol, 1012091471-2180
  35. 35. LittleJ. W1967An exonuclease induced by bacteriophage λ. II. Nature of the enzymatic reaction. J Biol Chem, 24246796860021-9258
  36. 36. LorenzM. GWackernagelW1994Bacterial gene transfer by natural genetic transformation in the environment.Microbiol Rev, 5835636020146-0749
  37. 37. MaloyS. RNunnW. D1981Selection for loss of tetracycline resistance by Escherichia coli.J Bacteriol, 1452111011110021-9193
  38. 38. MarescaMErlerAFuJFriedrichAZhangYStewartA. F2010Single-stranded heteroduplex intermediates in λ Red homologous recombination. BMC Mol Biol, 111541471-2199
  39. 39. MonteilhetCPerrinAThierryAColleauxLDujonB1990Purification and characterization of the in vitro activity of I-Sce I, a novel and highly specific endonuclease encoded by a group I intron.Nucleic Acids Res, 186140714130305-1048
  40. 40. MurphyK. C1991Gam protein inhibits the helicase and χ-stimulated recombination activities of Escherichia coli RecBCD enzyme. J Bacteriol, 17318580858210021-9193
  41. 41. MurphyK. C1998Use of bacteriophage λ recombination functions to promote gene replacement in Escherichia coli. J Bacteriol, 1808206320710021-9193
  42. 42. MuyrersJ. PZhangYBenesVTestaGAnsorgeWStewartA. F2000aPoint mutation of bacterial artificial chromosomes by ET recombinationEMBO Rep, 132392430146-9221X
  43. 43. Muyrers, J.P., Zhang, Y., Buchholz, F. & Stewart, A.F. (2000b). RecE/RecT and Redα/Redβ initiate double-stranded break repair by specifically interacting with their respective partners. Genes Dev, Vol.14, No.15, pp. 1971-1982, ISSN 0890-9369
  44. 44. NefedovMWilliamsonRIoannouP. A2000Insertion of disease-causing mutations in BACs by homologous recombination in Escherichia coli.Nucleic Acids Res, 2817E791362-4962
  45. 45. PassyS. IYuXLiZRaddingC. MEgelmanE. H1999Rings and filaments of β protein from bacteriophage L suggest a superfamily of recombination proteins. Proc Natl Acad Sci U S A, 968427942840027-8424
  46. 46. PelicicVReyratJ. MGicquelB1996Expression of the Bacillus subtilis sacB gene confers sucrose sensitivity on mycobacteria.J Bacteriol, 1784119711990021-9193
  47. 47. PodolskyTFongS. TLeeB. T1996Direct selection of tetracycline-sensitive Escherichia coli cells using nickel salts.Plasmid3621121150014-7619X
  48. 48. PósfaiGKolisnychenkoVBereczkiZBlattnerF. R1999Markerless gene replacement in Escherichia coli stimulated by a double-strand break in the chromosome.Nucleic Acids Res, 2722440944151362-4962
  49. 49. PoteeteA. R2001What makes the bacteriophage λ Red system useful for genetic engineering: molecular mechanism and biological function. FEMS microbiology letters, 20119140378-1097
  50. 50. QuénéeLLamotteDPolackB2005Combined sacB-based negative selection and cre-lox antibiotic marker recycling for efficient gene deletion in Pseudomonas aeruginosa.Biotechniques38163670736-6205
  51. 51. RanalloR. TBarnoySThakkarSUrickTVenkatesanM. M2006Developing live Shigella vaccines using λ Red recombineering. FEMS Immunol Med Microbiol, 4734624690928-8244
  52. 52. ReyratJ. MPelicicVGicquelBRappuoliR1998Counterselectable markers: untapped tools for bacterial genetics and pathogenesisInfect Immun, 669401140170019-9567
  53. 53. SawitzkeJAustinS2001An analysis of the factory model for chromosome replication and segregation in bacteria.Mol Microbiol, 4047867940095-0382X
  54. 54. SchweizerH. P2003Applications of the Saccharomyces cerevisiae Flp-FRT system in bacterial genetics. Journal of molecular microbiology and biotechnology, 5267771464-1801
  55. 55. SemseySKrishnaSSneppenKAdhyaS2007Signal integration in the galactose network of Escherichia coli. Mol Microbiol, 6524654760000-0950X
  56. 56. SpringerBKidanY. GPrammanananTEllrottKBöttgerE. CSanderP2001Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance. Antimicrobial agents and chemotherapy, 4510287728840066-4804
  57. 57. SunWWangSCurtissRrd (2008Highly efficient method for introducing successive multiple scarless gene deletions and markerless gene insertions into the Yersinia pestis chromosome. Appl Environ Microbiol, 7413424142451098-5336
  58. 58. SwaminathanSEllisH. MWatersL. SYuDLeeE. CCourtD. LSharanS. K2001Rapid engineering of bacterial artificial chromosomes using oligonucleotides. Genesis, 29114210152-6954X
  59. 59. TischerB. KSmithG. AOsterriederN2010En passant mutagenesis: a two step markerless red recombination system. In: In Vitro Mutagenesis Protocols: Third Edition, J. Braman (ed.), 421430Humana Press, 19406029York
  60. 60. TischerB. KVon EinemJKauferBOsterriederN2006Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques, 4021911970736-6205
  61. 61. UzzauSFigueroa-bossiNRubinoSBossiL2001Epitope tagging of chromosomal genes in Salmonella. Proc Natl Acad Sci U S A, 982615264152690027-8424
  62. 62. WangH. HIsaacsF. JCarrP. ASunZ. ZXuGForestC. RChurchG. M2009Programming cells by multiplex genome engineering and accelerated evolution. Nature, 46072578948981476-4687
  63. 63. WangJChenRJulinD. A2000A single nuclease active site of the Escherichia coli RecBCD enzyme catalyzes single-stranded DNA degradation in both directions. J Biol Chem, 27515075130021-9258
  64. 64. WarmingSCostantinoNCourtD. LJenkinsN. ACopelandN. G2005Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res, 334e361362-4962
  65. 65. WilleTBlankKSchmidtCVogtVGerlachR. G2012Gaussia princeps Luciferase as a Reporter for Transcriptional Activity, Protein Secretion, and Protein-Protein Interactions in Salmonella enterica Serovar Typhimurium. Appl Environ Microbiol, 7812502571098-5336
  66. 66. WongQ. NNgV. CLinM. CKungH. FChanDHuangJ. D2005Efficient and seamless DNA recombineering using a thymidylate synthase A selection system in Escherichia coli. Nucleic Acids Res, 336e591362-4962
  67. 67. YamamotoSIzumiyaHMoritaMArakawaEWatanabeH2009Application of λ Red recombination system to Vibrio cholerae genetics: Simple methods for inactivation and modification of chromosomal genes. Gene, 4381-257641879-0038
  68. 68. YuB. JKangK. HLeeJ. HSungB. HKimM. SKimS. C2008Rapid and efficient construction of markerless deletions in the Escherichia coli genome. Nucleic Acids Res, 3614e841362-4962
  69. 69. YuDEllisH. MLeeE. CJenkinsN. ACopelandN. GCourtD. L2000An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci U S A, 9711597859830027-8424
  70. 70. ZhangYBuchholzFMuyrersJ. PStewartA. F1998A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet, 2021231281061-4036
  71. 71. ZhangYMuyrersJ. PTestaGStewartA. F2000DNA cloning by homologous recombination in Escherichia coli. Nat Biotechnol, 1812131413171087-0156
  72. 72. ZhangZLutzB2002Cre recombinase-mediated inversion using lox66 and lox71: method to introduce conditional point mutations into the CREB-binding protein. Nucleic Acids Res, 3017e901362-4962

Written By

Roman G. Gerlach, Kathrin Blank and Thorsten Wille

Submitted: 06 May 2011 Published: 05 February 2013